EYENUK, INC.
Automated AI software tool for lesion characterization and diabetic retinopathy grading in ultra-widefield scanning laser ophthalmoscopy images
- Sector
- Digital health
- Headquarters
- WOODLAND HILLS, CA
- Founded
- 2013
- Latest Form D
- $5.6M, Jun 2026
- Total capital
- $42.7M
- Federal grants
- $8.8M
- 15 awards · 2015–2022
- Rank in peer group#2 of 32
- Private capital raised
- $33.9M
- 5 Form D · last Jun 2026
- 4 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 16 pending · first 2014
- Rank in peer group#3 of 32
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$5.6M
- Federal grantHealth and Human S · Phase II · Fully-Automated Lesion Characterization in Ultrawide-Field Retinal Images$250K
- Private capital raisedForm D · SEC · 4th filing$22.4M
- Federal grantHealth and Human S · Phase II · Fully-Automated Lesion Characterization in Ultrawide-Field Retinal Images$748K
- Federal grantHealth and Human S · Phase II · Fully-Automated Lesion Characterization in Ultrawide-Field Retinal Images$1M
- Federal grantHealth and Human S · Phase I · AI-enabled fully automated retinal image-based biomarkers for mild cognitive impairment and neurodegenerative disorders$224K
- Federal grantHealth and Human S · Phase I · Automated end-to-end retinal screening system with robotic image capture and deep learning analysis$219K
- Private capital raisedForm D · SEC · 3rd filing$3M
- Private capital raisedForm D · SEC · 2nd filing$1.4M
- Private capital raisedForm D · SEC · 1st filing$1.5M
Show 10 earlier federal awards
- Federal grantHealth and Human S · Phase II · Automated image-based biomarker computation tools for diabetic retinopathy$750K
- Federal grantHealth and Human S · Phase II · Automated image-based biomarker computation tools for diabetic retinopathy$750K
- Federal grantHealth and Human S · Phase I · Fully-automated lesion characterization in ultrawide-field retinal images$216K
- Federal grantHealth and Human S · Phase II · Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Application$513K
- Federal grantHealth and Human S · Phase I · Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Application$1.5M
- Federal grantHealth and Human S · Phase II · Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Application$1M
- Federal grantHealth and Human S · Phase II · Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy$483K
- Federal grantHealth and Human S · Phase I · Advanced retinal image analysis for AMD screening$225K
- Federal grantHealth and Human S · Phase II · Automated Image-based Biomarker Computation Tools for Diabetic Retinopathy$499K
- Federal grantHealth and Human S · Phase II · Advanced Image Analysis Tools for Diabetic Retinopathy Telemedicine Applications$394K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
13months
from EYENUK, INC.’s first federal award to its first private round.
- First federal award · Jun 2015
- Health and Human S · $394K
- First Form D · Jul 2016
- $1.5M · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 32 peers
Line = medianDigital health · Software
- Federal grants#2 · top 6%
- Granted patents#3 · top 9%
- Linked publications#3 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Kaushal SolankiResearcherDirectorLinked by $5.2M in grants as PI
- Frank ChengExecutive OfficerNamed in SEC Form D filings
- Gaurav AgarwalExecutive Officer, DirectorNamed in SEC Form D filings
- Mads DallDirectorNamed in SEC Form D filings
- Manish PottiDirectorNamed in SEC Form D filings
- Marie-Louise LittleDirectorNamed in SEC Form D filings
Show all 9 people
- Martin CoyneDirectorNamed in SEC Form D filings
- Robert BinneyDirectorNamed in SEC Form D filings
- Zina Affas BesseDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 22- PendingSystems And Methods For Automated End-to-end Eye Screening, Monitoring And DiagnosisUSPTOApplication 19302523
- PendingSystems And Apparatuses For Three-dimensional Eye Imaging For Screening, Monitoring, And Diagnosis Of DiseasesUSPTOApplication 19276341
- PendingSystems And Methods For Automated Processing Of Retinal ImagesUSPTOApplication 19205203
Show all 22 patent records
- Systems And Methods For Automated End-to-end Eye Screening, Monitoring And DiagnosisMar 12, 2026 · Application 19302523Pending
- Systems And Apparatuses For Three-dimensional Eye Imaging For Screening, Monitoring, And Diagnosis Of DiseasesFeb 19, 2026 · Application 19276341Pending
- Systems And Methods For Automated Processing Of Retinal ImagesDec 11, 2025 · Application 19205203Pending
- Systems And Apparatuses For Three-dimensional Eye Imaging For Screening, Monitoring, And Diagnosis Of DiseasesAug 19, 2025 · US 12,390,107Granted
- Systems, Methods, And Apparatuses For Eye Imaging, Screening, Monitoring, And DiagnosisMar 4, 2025 · US 12,239,378Granted
- Systems And Methods For Automated Processing Of Retinal ImagesJan 9, 2025 · Application 18676179Pending
- Systems And Methods For Automated Processing Of Retinal ImagesApr 25, 2024 · Application 18215696Pending
- Systems And Methods For Automated End-to-end Eye Screening, Monitoring And DiagnosisApr 18, 2024 · Application 18142991Pending
- Systems And Methods For Automated Processing Of Retinal ImagesFeb 2, 2023 · Application 17838103Pending
- Systems And Methods For Enhancement Of Retinal ImagesNov 11, 2021 · Application 17121739Pending
- Systems And Methods For Enhancement Of Retinal ImagesAug 13, 2020 · Application 16731837Pending
- Systems And Methods For Enhancement Of Retinal ImagesFeb 7, 2019 · Application 16039268Pending
- Systems And Methods For Enhancement Of Retinal ImagesFeb 9, 2017 · Application 15242303Pending
- Systems And Methods For Automated Detection Of Regions Of Interest In Retinal ImagesFeb 9, 2017 · Application 15238674Pending
- Systems And Methods For Automated Detection Of Regions Of Interest In Retinal ImagesApr 23, 2015 · Application 14500929Pending
- Systems And Methods For Enhancement Of Retinal ImagesApr 23, 2015 · Application 14507777Pending
- Systems And Methods For Processing Retinal Images For Screening Of Diseases Or AbnormalitiesApr 14, 2015 · US 9,008,391Granted
- Systems And Methods For Automatically Generating Descriptions Of Retinal ImagesApr 7, 2015 · US 9,002,085Granted
- Systems And Methods For Automated Enhancement Of Retinal ImagesNov 11, 2014 · US 8,885,901Granted
- Systems And Methods For Automated Interest Region Detection In Retinal ImagesNov 4, 2014 · US 8,879,813Granted
- Systems And Methods For Automated Analysis Of Retinal ImagesApplication PCTUS2014036250Pending
- Systems, Methods, And Apparatuses For Eye Imaging, Screening, Monitoring, And DiagnosisApplication PCTUS2019063230Pending
Recent research by its founders
- Predicting progression to proliferative diabetic retinopathy using automated versus manual quantification of retinal haemorrhages20261 cites
- Diabetic Retinopathy Screening Among Federally Qualified Health Center Patients Using Point-of-Care AI20258 cites
- Artificial Intelligence Detection of Diabetic Retinopathy2022148 cites
Related companies, and why
- SOFTHREAD, INC.Similar federal contract value in Digital health · null in contracts
- Verantos, Inc.Similar federal contract value in Digital health · null in contracts
- HIDALGA TECHNOLOGIES, LLCSimilar federal contract value in Digital health · null in contracts
- ZEBRAMD INC.Similar federal contract value in Digital health · null in contracts
- Canal 33 Inc.Similar federal contract value in Digital health · null in contracts
- DRIVEABILITY VT, LLCSimilar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .